CLRB
Price:
$2.08
Market Cap:
$74.57M
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients; and Phase I study for various pediatric cancers, r/r head and neck cancers, and R/R MM. The company also develops CLR 1900, a PDC chemotherapeutic program that is in the preclinical development stage to treat solid tumors. It has collaborative PDC p...[Read more]
Industry
Biotechnology
IPO Date
2005-11-10
Stock Exchange
NASDAQ
Ticker
CLRB
According to Cellectar Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.54. This represents a change of 86.91% compared to the average of 1.36 of the last 4 quarters.
The mean historical Current Ratio of Cellectar Biosciences, Inc. over the last ten years is 6.05. The current 2.54 Current Ratio has changed 4.11% with respect to the historical average. Over the past ten years (40 quarters), CLRB's Current Ratio was at its highest in in the December 2020 quarter at 16.26. The Current Ratio was at its lowest in in the June 2014 quarter at 0.49.
Average
6.05
Median
4.81
Minimum
0.73
Maximum
16.26
Discovering the peaks and valleys of Cellectar Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 918.67%
Maximum Annual Current Ratio = 16.26
Minimum Annual Increase = -83.49%
Minimum Annual Current Ratio = 0.73
Year | Current Ratio | Change |
---|---|---|
2023 | 0.81 | -78.24% |
2022 | 3.71 | -59.49% |
2021 | 9.16 | -43.64% |
2020 | 16.26 | 295.58% |
2019 | 4.11 | -52.21% |
2018 | 8.60 | 66.27% |
2017 | 5.17 | -30.73% |
2016 | 7.47 | 918.67% |
2015 | 0.73 | -83.49% |
2014 | 4.44 | 625.42% |
The current Current Ratio of Cellectar Biosciences, Inc. (CLRB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.56
5-year avg
6.81
10-year avg
6.05
Cellectar Biosciences, Inc.’s Current Ratio is less than Diffusion Pharmaceuticals Inc. (0), less than Monopar Therapeutics Inc. (10.96), less than Pulmatrix, Inc. (6.59), less than Tenax Therapeutics, Inc. (6.33), less than Bio-Path Holdings, Inc. (6.10), greater than Catalyst Biosciences, Inc. (1.67), greater than Capricor Therapeutics, Inc. (0), greater than NextCure, Inc. (1.37), less than Longboard Pharmaceuticals, Inc. (8.35), less than Lumos Pharma, Inc. (20.95), less than ImmunoCellular Therapeutics, Ltd. (4.23), greater than Bolt Biotherapeutics, Inc. (0), less than Applied Molecular Transport Inc. (4.28), less than Aileron Therapeutics, Inc. (4.99), less than Benitec Biopharma Inc. (4.69), less than null (4.18),
Company | Current Ratio | Market cap |
---|---|---|
0 | $8.98M | |
10.96 | $8.41M | |
6.59 | $7.30M | |
6.33 | $12.54M | |
6.10 | $2.51M | |
1.67 | $19.42M | |
0 | $132.76M | |
1.37 | $39.73M | |
8.35 | $1.36B | |
20.95 | $30.87M | |
4.23 | $19.14M | |
0 | $24.78M | |
4.28 | $11.01M | |
4.99 | $60.66M | |
4.69 | $90.98M | |
4.18 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cellectar Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cellectar Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Cellectar Biosciences, Inc.'s Current Ratio?
How is the Current Ratio calculated for Cellectar Biosciences, Inc. (CLRB)?
What is the highest Current Ratio for Cellectar Biosciences, Inc. (CLRB)?
What is the 3-year average Current Ratio for Cellectar Biosciences, Inc. (CLRB)?
What is the 5-year average Current Ratio for Cellectar Biosciences, Inc. (CLRB)?
How does the current Current Ratio for Cellectar Biosciences, Inc. (CLRB) compare to its historical average?